Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ORBOTECH LTD | ORBK | 10.86% |
| SONIC FOUNDR | SOFO | 9.45% |
| VIPSHOP HOLD | VIPS | 9.20% |
| RENEWABLE EN | REGI | 8.98% |
| EAGLE BULK S | EGLE | 7.84% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Company Description
Omnicell provides automated and business information solution for hospitals and healthcare companies.
Tic Tac Toe
3 earnings surprises in a row. On Oct 27 Omnicell reported quarterly results that included EPS at $0.09, a penny better than the Zacks Consensus Estimate.
Revenue was up more than 14%, to $64.4 million. That doubled net income from $1.3 million to $2.6 million. The CEO said "The marketplace continues to be very receptive" to the company's new platform and market share is growing.
Strong Growth Rates
Analysts polled by Zacks are expecting full year earnings to come in at $0.27, which is more than double the $0.13 earned in 2010.
Next year's average projection is up 2 cents, to $0.42 for a 52% growth rate. While those, and the long-term growth rate of 27%, are impressive, it is more than priced into the stock. Shares are going for almost 60 times estimates, giving OMCL a PEG of 2.2.
The industry is doing well in general, ranking 74th out of 265 and Omnicell is the top rated of 14 companies.
The Chart
Shares of OMCL responded well to the earnings news and are now pressuring the 52-week high. It could be tough to pull the trigger and buy at these levels, but if the stock gets past this point there is a lot of room to run.
Bill Wilton is the Aggressive Growth Stock Strategist for Zacks.com. He is also the Editor in charge of the Zacks Small Cap Trader service
Read the full Analyst Report on OMCL